ATE285212T1 - Absorptionsförderer für topische pharmazeutische formulierungen - Google Patents

Absorptionsförderer für topische pharmazeutische formulierungen

Info

Publication number
ATE285212T1
ATE285212T1 AT94930744T AT94930744T ATE285212T1 AT E285212 T1 ATE285212 T1 AT E285212T1 AT 94930744 T AT94930744 T AT 94930744T AT 94930744 T AT94930744 T AT 94930744T AT E285212 T1 ATE285212 T1 AT E285212T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
topical pharmaceutical
absorption promoters
enhancers
dimethylamino
Prior art date
Application number
AT94930744T
Other languages
English (en)
Inventor
Servet Bueyuektimkin
Nadir Bueyuektimkin
Joseph Howard Rytting
Original Assignee
Odontex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Odontex Inc filed Critical Odontex Inc
Application granted granted Critical
Publication of ATE285212T1 publication Critical patent/ATE285212T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94930744T 1993-10-07 1994-10-07 Absorptionsförderer für topische pharmazeutische formulierungen ATE285212T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13345493A 1993-10-07 1993-10-07
PCT/US1994/011597 WO1995009590A1 (en) 1993-10-07 1994-10-07 Absorption enhancers for topical pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE285212T1 true ATE285212T1 (de) 2005-01-15

Family

ID=22458697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94930744T ATE285212T1 (de) 1993-10-07 1994-10-07 Absorptionsförderer für topische pharmazeutische formulierungen

Country Status (10)

Country Link
EP (1) EP0746294B1 (de)
CN (1) CN1133465C (de)
AT (1) ATE285212T1 (de)
AU (1) AU7977294A (de)
CA (1) CA2178594C (de)
DE (1) DE69434199T2 (de)
ES (1) ES2233933T3 (de)
PT (1) PT746294E (de)
RU (1) RU2165265C2 (de)
WO (1) WO1995009590A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295797B6 (cs) * 1997-04-04 2005-11-16 Bochemie, S.R.O. Sloučeniny na bázi derivátů omega-aminokyselin, způsob jejich výroby a jejich použití
NZ542904A (en) * 2003-03-21 2009-04-30 Nexmed Holdings Inc Antifungal nail coat and method of use
JP2006522136A (ja) 2003-04-02 2006-09-28 ネックスメド ホールディングス インコーポレイテッド プロスタグランジン組成物および血管痙攣の治療のためのその使用
CA2590136A1 (en) 2004-12-10 2006-06-15 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
MX2010009148A (es) * 2008-02-28 2010-12-06 Toray Industries Composicion farmaceutica para la administracion transnasal.
CN104800147A (zh) * 2008-07-10 2015-07-29 德勒尼克斯治疗股份公司 用于大分子的增强的递送的方法和组合物
RU2765463C2 (ru) * 2008-12-04 2022-01-31 Чунси ЮЙ Композиции интенсивного проникновения и их применение
CA2838109C (en) 2011-04-07 2020-06-09 Nexmed Holdings, Inc. Topical semisolid prostaglandin e1 composition for treating raynaud's disease
DE102013004199A1 (de) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische Zusammensetzung
JP2016514024A (ja) 2013-03-14 2016-05-19 ハラックス，インコーポレイテッド 爪部の感染症、疾患または障害の治療方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
US4732892A (en) * 1985-07-12 1988-03-22 American Home Products Corporation L-α-amino acids as transdermal penetration enhancers
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
US4980378A (en) * 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
AU664178B2 (en) * 1991-03-19 1995-11-09 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers

Also Published As

Publication number Publication date
ES2233933T3 (es) 2005-06-16
EP0746294A4 (de) 1998-04-22
DE69434199D1 (de) 2005-01-27
CA2178594A1 (en) 1995-04-13
CA2178594C (en) 2008-12-23
PT746294E (pt) 2005-03-31
RU2165265C2 (ru) 2001-04-20
EP0746294A1 (de) 1996-12-11
DE69434199T2 (de) 2005-12-29
CN1140983A (zh) 1997-01-22
WO1995009590A1 (en) 1995-04-13
EP0746294B1 (de) 2004-12-22
CN1133465C (zh) 2004-01-07
AU7977294A (en) 1995-05-01

Similar Documents

Publication Publication Date Title
ATE285212T1 (de) Absorptionsförderer für topische pharmazeutische formulierungen
DE69229098D1 (de) Hochdosierte topische Kollagenaseformen
LV11279A (lv) Farmaceitiska kompozicija kas satur nervu augsanas faktoru
ATE202476T1 (de) Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam
ATE455535T1 (de) Topische zusammensetzungen zur verabreichung von prostaglandin e1
ES2075011T3 (es) Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
DE69332350T2 (de) Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen
MX9301053A (es) Guanidinas [(benzodioxan, benzofuran o benzopiran)-alquilamino]-alquil-substituidas.
BR9403783A (pt) Uso de uma composição cosmética
ES2028796T3 (es) Procedimiento para producir preparados farmaceuticos que contienen interferon alfa.
ATE94765T1 (de) Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen.
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
NO934107D0 (no) Penetrasjonsfremmende substans
BR9808215A (pt) Preparados de adesivos para lacas, sua preparação e emprego
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
ES2078256T3 (es) Formula farmaceutica para uso topico que contiene diclofenaco sodico.
DE3776111D1 (de) Pharmazeutische zubereitungen.
DE3881254D1 (de) Pharmazeutische zusammensetzung.
ES2174176T3 (es) Procedimiento para reducir el daño en tejido asociado con la isquemia.
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
TR199701463T1 (en) Sorbin asiti i�eren hidrojel.
IT8848562A0 (it) Preparazioni farmaceutiche per uso topico a base di eparina, eparinoidi e frazioni, lnw eparina e vlmweparina dotate di elevato assorbimento transdermico per la presenza di esteri di colina
MX9205702A (es) Composicion que comprende un material de tramadol y acetaminofen y su uso.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0746294

Country of ref document: EP